Safety Extension Study of TRO19622 in ALS

Clinical trial NCT01285583 · COMPLETED

Trial details

NCT number: NCT01285583
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2010-10-01
Primary completion: 2012-03-01
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.